Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...